Clinical Trial

ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

Recruiting
View on ClinicalTrials.gov →
Summary
This research is being done to find out more information about a brain tumor called Embryonal Tumor with Multilayer Rosettes (ETMR) by collecting medical information from children who have this disease. The purpose of this research study is to create and maintain a research database for patients with ETMR. The database will include information about occurrence rates, patient information, tumor tissue information, and response to treatment. This will help advance our understanding of this rare disease. In addition, this study will include obtaining survival data and evaluating therapeutic response to expert consensus therapy, and procuring patient tumor tissue.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2021-03-09; most recent amendment 2026-05-29.
Trial Details
NCT Number NCT04794686
Lead Sponsor Hackensack Meridian Health
Conditions Embryonal Tumor With Multilayered Rosettes
Enrollment 100 participants
Start Date 2020-07-12
Primary Completion 2030-07-12 (estimated)
Study Completion 2030-07-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-02